06.03.2021 Views

Beauty Turkey March 2021

Beauty Turkey March 2021

Beauty Turkey March 2021

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Güzellik<br />

<strong>Beauty</strong><br />

49<br />

During the pandemic period, especially disinfectant and<br />

cologne broke records. There was an increase in demand for<br />

hygiene and cleaning products, pharmaceuticals and medical<br />

products, disposable plastic products and packaging products.<br />

During the pandemic period, our exports of Covid-19 products,<br />

including disinfectants, cologne, medicine, soap and diagnostic<br />

kits in the chemical substances and products sector, increased<br />

by 212.73 percent in 2020 compared to 2019, reaching 524.4<br />

million dollars.<br />

According to the data of the first three quarters of 2020, while<br />

the chemical industry exports decreased by 23.1 percent in<br />

the world, the Turkish chemical industry exports decreased by<br />

only 4.6 percent. The share of our industry in world exports<br />

increased and became 0.7.<br />

What are your future predictions for the impact of the<br />

pandemic on the sectors? What are your suggestions for the<br />

industry to turn the crisis into an opportunity in this period?<br />

In the fight against pandemic, it is necessary to increase market<br />

diversity in order to minimize the risk in exports. Our chemical<br />

industry, on the other hand, comes first among 27 sectors with<br />

the most exports to countries and regions every month. The<br />

pandemic has shown us the importance of domestic production<br />

in supply and the need not to depend on one place. In the new<br />

order that will occur after the pandemic, it seems that digital<br />

transformation, e-commerce, e-export and artificial intelligence<br />

will occupy our agenda more. Our export companies need to<br />

prioritize these issues in this regard and invest in branding,<br />

R&D and innovation.<br />

After the pandemic, our country is expected to stand out in<br />

terms of logistics and supply. In order for our companies to<br />

benefit from these opportunities, it is of great importance that<br />

they increase their capital, increase their production capacity,<br />

and switch to environment-friendly and value-added product<br />

production structures. Considering the European Green<br />

Consensus, the production of green products targeting zero<br />

carbon emission will provide an advantage in exports and will<br />

also appear as a necessity.<br />

In particular, in the socio-economic order that is predicted to<br />

be newly established, the importance of the chemical sector<br />

will increase in terms of producing drugs, vaccines and medical<br />

products in our country and fighting more effectively in possible<br />

viral epidemics. It should also be made possible to produce<br />

domestic production in these areas and high-tech products in<br />

the field of biological medicine.<br />

Pandemi sonrası oluşacak yeni düzende dijital dönüşüm,<br />

e-ticaret, e-ihracat, yapay zeka konuları gündemimizi daha<br />

çok meşgul edecek gibi görünüyor. İhracatçı firmalarımızın bu<br />

açıdan bu konulara öncelik vermeleri ve yine markalaşmaya, arge<br />

ve inovasyona yatırım yapmaları gerekiyor.<br />

Pandemi sonrası ülkemizin lojistik ve tedarik bakımından öne<br />

çıkması bekleniyor. Firmalarımızın da bu oluşacak fırsatlardan<br />

yararlanabilmesi için sermayelerini arttırmaları, üretim<br />

kapasitelerini arttırmaları, çevreye duyarlı ve katma değerli<br />

ürün üretim yapılarına geçmeleri büyük önem taşıyor. Avrupa<br />

Yeşil Mutabakat’ını da göz önünde bulundurursak sıfır karbon<br />

emisyonu hedefleyen yeşil ürünlerin üretimi ihracatta avantaj<br />

sağlarken aynı zamanda bir zorunluluk olarak da karşımıza<br />

çıkacak.<br />

Özellikle, yeni kurulacağı öngörülen sosyo ekonomik düzende<br />

kimya sektörünün ilaç, aşı ve medikal ürünlerin ülkemizde<br />

üretilebilmesi ve muhtemel virütik salgınlarda daha etkin<br />

mücadele edebilmesi noktasında önemi artacak. Bu alanlarda<br />

yerli üretimin ve biyolojik ilaç alanında da yüksek teknolojili<br />

ürünlerin üretilebilmesi de mümkün kılınmalı.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!